Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study

March 17, 2017 updated by: Joslin Diabetes Center

A Pilot Study of the Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diet to Typical American Diets

We hypothesize that Asian Americans compared to Caucasians, will be at higher risk of developing a pro-inflammatory state that may contribute to the development of heart disease and diabetes when they change from a traditional Asian diet to a typical Western diet. These inflammatory responses will be reflected by the activation of monocytes as measured by protein kinase C (PKC), a known activator of monocytes.

We also hypothesize that the changes of these inflammatory responses in the gingival crevicular fluid (GCF) will reflect similar changes of these markers in the plasma and monocytes.

Specific aims:

  1. To compare the inflammatory responses (primarily PKC activation in monocytes), between Far-East Asian Americans and Caucasian Americans, when they change from a traditional Asian diet to a typical American diet.
  2. To correlate the biochemical changes of inflammatory responses in the plasma and monocytes with those in the gingival crevicular fluid (GCF).

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Joslin Diabetes Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Caucasian or Far-East Asian decent
  2. Ages between 25 - 55 years old
  3. Has family history of diabetes defined as having a first degree relative diagnosed with diabetes mellitus, and/or medical history of gestational diabetes (GDM), impaired fasting glucose(IFG) and impaired glucose tolerance (IGT)
  4. BMI of 18.5 - 25.0 kg/m2
  5. Agree to maintain constant physical activity levels for the duration of the study
  6. Agree to utilize contraception for the duration of the study (for female subjects)
  7. Have a minimum of 12 natural teeth
  8. Scoring of 2 or more on dental screening questionnaire (See appendix)
  9. Ability to communicate in English

Exclusion Criteria:

  1. Acute weight loss/weight gain over the past 6 months (defined as +4 lbs or more/month)
  2. History of diabetes
  3. Current Smokers (including those who quit < 1 year)
  4. Heavy alcohol drinkers, defined as drinking more than 7 drinks/week. Those who drink alcohol will need to be reported and documented. They will be asked to maintain the levels of alcohol consumption throughout the study.
  5. Medical history of vascular diseases (CAD, MI, stroke, CABG, angioplasty), diabetes, liver disease, kidney disease, cancer, AIDS, bleeding disorders
  6. History of food allergies or to any food products in the diet menu.
  7. Enrolled in another investigational study within 1 month prior to screening for this study
  8. Vegetarian, those with significant food aversions, and anyone who cannot comply with the diet
  9. Pregnancy or breasting feeding
  10. Other autoimmune or inflammatory conditions or diseases that may compromise the patient's safety or compliance during the study on an individual basis
  11. Chronic use of antibiotics or anti-inflammatory medications (>1 month) within the past year
  12. On medications such as statins, angiotensin converting enzyme inhibitor, warfarin, aspirin or other anti-inflammatory medications. Daily multivitamins are permitted, excluding pharmacological doses of anti- oxidants will not be allowed.
  13. Individuals with dental needs requiring extensive dental restorations such as cavities, root canals, crowns, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 1
Control group- subjects are on the Asian diet for the entire duration of the study
Experimental: 2
Asian and Caucasian subjects switch from an Asian Diet to a Western Diet midway through the study.
Intervention groups include: Asian intervention and Caucasian intervention- both these groups switch from an Asian diet to a Western diet halfway through the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in inflammatory markers including PKC and IL6 and Gingival Crevicular Fluid
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
Lipid profiles
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
Blood glucose levels
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
Body Fat percentage assessed by Dual X-ray Absorption
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
Insulin resistance assessed by HOMA
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: George L King, MD, Joslin Diabetes Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2005

Primary Completion (Actual)

July 1, 2008

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

September 21, 2006

First Submitted That Met QC Criteria

September 21, 2006

First Posted (Estimate)

September 22, 2006

Study Record Updates

Last Update Posted (Actual)

March 20, 2017

Last Update Submitted That Met QC Criteria

March 17, 2017

Last Verified

March 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on 2 groups of population responding to 2 types of diets

3
Subscribe